Bob my #1 is CYTX they are 5 years ahead of everyone and could be the ISRG of regenerative medicine. The company's PureGraft technology allows for a patient's own fat tissue to be prepared for aesthetically contouring re-injection after just fifteen minutes. My favorite.
#2 is GERN the leader and the 100 pound gorilla as far as embryonic stem cells. IMO the most potential. Had been on a tear till they postponed their spinal cord paralysis trial because they wanted to broaden the trial from thoracic to include cervical spinal cord injuies, will resume this summer.
#3 is BTIM they have developed the most lines of stem cell that IMO will be approved in the near future by the NIH, and could be the Google of stem cells. The CEO founded GERN and also cofounded ACTC and is considered the pioneer and most renowned in the stem cell field
#4 is CUR literally just performed the first stem cell trial for ALS or Lou Gehrig's disease this week. Ran up in anticipation of the study.
#5 is ACTC that has submitted to the FDA for the first treatment for blindness. Very similar situation as Biocurex with dilution and false starts, but hold tremendous patents IP.
#6 is OPXA up on their positive MS trial and are now have a deal with major pharma for 50 million upfront and up to another 500 million in royalties.
#7 is ISCO another stem cell company that has the IP rights to several new lines of stem cells
#8 is ATHX just did a deal with Pfizer for its multistem in the treatment of irritable bowel disease.
#9 is KOOL they sell the equipment to stem cell companies
#10 is NBS they ared in the pre-disease collection, processing and long-term storage of adult stem cells for the general population to use in future medical applications that is expanding in China for the commercialization of regenerative medicine and other stem cell applicatons.
#11 is SCLZ that utilizes state of the art technology to extract and concentrate your body's own regenerative cells to produce natural results. Clients are matched up with renowned physicians in their geographic region.
#12 is OSIR and has collaboration agreements with Genzyme Corporation for the development and commercialization of Prochymal and Chondrogen
#13 is STEM great IP and owns rights to many stem cell lines. My problem with STEM which I own for many years is they have been targeting obscure diseases. Their findings will however, be applicable to many other neurogenic disorders.
#14 is ASTM a complete diaster and cost me alot of money. They have lost the street's confidence and certainly mine. They are in phase 111 for heart disease.
#15 is PSTI engages in the research, development, and production of placental-derived adherent stromal cells. Israeli company that I like because they are not using embryonic stem cells which are the most controversial
Bob, there are others, but there you go. Best of luck.
